Virtual reality headsets tested to ease needle pain in young leukemia patients
NCT ID NCT06697275
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a virtual reality headset can reduce pain and anxiety in children aged 6 to 16 with leukemia when they get a needle placed into a port. About 120 kids will be randomly assigned to use either a hypnotic VR, an interactive VR, or standard care (numbing cream and distraction). The goal is to see if repeated VR use over three months makes needle sticks less painful and less scary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Virtual reality (hypnotic or interactive) via Deepsen® mask with Birdy® software
What this could lead to
If it works, this could offer a drug-free way to ease pain and fear during repeated needle procedures for children with leukemia.
What could go wrong
This is a relatively small, early-stage trial (120 participants) testing a device, not a drug. The effect may be small or not better than standard distraction techniques.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assistance Publique - Hôpitaux de Marseille
RECRUITINGMarseille, 13005, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Bordeaux
RECRUITINGBordeaux, 33000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, 63000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Toulouse
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact